{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T03:11:10Z","timestamp":1778037070003,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key R&D Plan for Intergovernmental Cooperation, the Ministry of Science and Technology of China","award":["2022YFE0133100"],"award-info":[{"award-number":["2022YFE0133100"]}]},{"name":"National Key R&D Plan for Intergovernmental Cooperation, the Ministry of Science and Technology of China","award":["2022YFE0133100"],"award-info":[{"award-number":["2022YFE0133100"]}]},{"name":"National Key R&D Plan for Intergovernmental Cooperation, the Ministry of Science and Technology of China","award":["2022YFE0133100"],"award-info":[{"award-number":["2022YFE0133100"]}]},{"name":"Foundation of State Key Laboratory of Ultrasound in Medicine and Engineering","award":["2024KFKT016"],"award-info":[{"award-number":["2024KFKT016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-026-02074-1","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:52:54Z","timestamp":1773816774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Two cycles of chemotherapy modulate itaconic acid levels via ATF3\/TET2\/NF-\u03baB pathways in ovarian cancer among Han Chinese women"],"prefix":"10.1186","volume":"19","author":[{"given":"Ying","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-ya","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-ming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-qi","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-ling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-li","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-quan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"issue":"4","key":"2074_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, et al. Ovarian cancer statistics, 2018. Cancer J Clin. 2018;68(4):284\u201396.","journal-title":"Cancer J Clin"},{"issue":"9","key":"2074_CR2","doi-asserted-by":"publisher","first-page":"972","DOI":"10.6004\/jnccn.2022.0047","volume":"20","author":"DK Armstrong","year":"2022","unstructured":"Armstrong DK, Alvarez RD, Backes FJ, et al. NCCN Guidelines\u00ae Insights: Ovarian Cancer, Version 3.2022. J Natl Compr Cancer Network: JNCCN. 2022;20(9):972\u201380.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"16","key":"2074_CR3","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1177\/15353702211023846","volume":"246","author":"W Zhang","year":"2021","unstructured":"Zhang W, Torres-Rojas C, Yue J, Zhu BM. Adipose-derived stem cells in ovarian cancer progression, metastasis, and chemoresistance. Experimental biology Med (Maywood NJ). 2021;246(16):1810\u20135.","journal-title":"Experimental biology Med (Maywood NJ)"},{"key":"2074_CR4","doi-asserted-by":"crossref","unstructured":"Kumar A, Cliby WA. Advanced Ovarian Cancer: Weighing the Risks and Benefits of Surgery. Clin Obstet Gynecol. 2020;63(1):74\u20139.","DOI":"10.1097\/GRF.0000000000000497"},{"issue":"1","key":"2074_CR5","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2074_CR6","first-page":"221","volume":"46","author":"R Zheng","year":"2024","unstructured":"Zheng R, Chen R, Han B. Cancer incidence and mortality in China, 2022. Zhonghua Zhong Liu Za Zhi. 2024;46(3):221\u201331.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"4","key":"2074_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3322\/caac.21559","volume":"69","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: Evolution of management in the era of precision medicine. Cancer J Clin. 2019;69(4):280\u2013304.","journal-title":"Cancer J Clin"},{"key":"2074_CR8","doi-asserted-by":"crossref","unstructured":"Chudecka-G\u0142az A, Strojna A, Michalczyk K et al. Evaluation of He4 use in the diagnosis of ovarian cancer: first and second recurrence, and an analysis of HE4 concentration during second- and third-line chemotherapy. Diagnostics (Basel Switzerland). 2023;13(3):452.","DOI":"10.3390\/diagnostics13030452"},{"key":"2074_CR9","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.2147\/OTT.S150456","volume":"10","author":"L Cui","year":"2017","unstructured":"Cui L, Zhao Y, Pan Y, et al. Chemotherapy induces ovarian cancer cell repopulation through the caspase 3-mediated arachidonic acid metabolic pathway. OncoTargets therapy. 2017;10:5817\u201326.","journal-title":"OncoTargets therapy"},{"issue":"1","key":"2074_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41698-023-00454-0","volume":"7","author":"S Corvigno","year":"2023","unstructured":"Corvigno S, Badal S, Spradlin ML, et al. In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy. NPJ precision Oncol. 2023;7(1):115.","journal-title":"NPJ precision Oncol"},{"issue":"3","key":"2074_CR11","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.3802\/jgo.2022.33.e28","volume":"33","author":"YS Chung","year":"2022","unstructured":"Chung YS, Kim Y, Kim HS, et al. Prognostic value of complete metabolic response on \u00b9\u2078F-FDG-PET\/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer. J Gynecol Oncol. 2022;33(3):e28.","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"2074_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12986-023-00744-1","volume":"20","author":"X Liu","year":"2023","unstructured":"Liu X, Yang J, Ran R, et al. Chorionicity-associated variation in metabolic phenotype of cord blood in twin. Nutr metabolism. 2023;20(1):31.","journal-title":"Nutr metabolism"},{"issue":"10","key":"2074_CR13","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1038\/nprot.2010.108","volume":"5","author":"KF Smart","year":"2010","unstructured":"Smart KF, Aggio RB, Van Houtte JR, Villas-B\u00f4as SG. Analytical platform for metabolome analysis of microbial cells using methyl chloroformate derivatization followed by gas chromatography-mass spectrometry. Nat Protoc. 2010;5(10):1709\u201329.","journal-title":"Nat Protoc"},{"key":"2074_CR14","doi-asserted-by":"publisher","first-page":"916375","DOI":"10.3389\/fonc.2022.916375","volume":"12","author":"X Zhong","year":"2022","unstructured":"Zhong X, Ran R, Gao S, et al. Complex metabolic interactions between ovary, plasma, urine, and hair in ovarian cancer. Front Oncol. 2022;12:916375.","journal-title":"Front Oncol"},{"key":"2074_CR15","doi-asserted-by":"crossref","unstructured":"Jiang W, Zhang T, Zhang H et al. Metabolic patterns of high-invasive and low-invasive oral squamous cell carcinoma cells using quantitative metabolomics and (13)C-glucose tracing. Biomolecules. 2023;13(12):1806.","DOI":"10.3390\/biom13121806"},{"issue":"6","key":"2074_CR16","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/jcsm.12804","volume":"12","author":"J Ubachs","year":"2021","unstructured":"Ubachs J, Ziemons J, Soons Z, et al. Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients. J cachexia sarcopenia muscle. 2021;12(6):2007\u201321.","journal-title":"J cachexia sarcopenia muscle"},{"issue":"9","key":"2074_CR17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1808424","volume":"380","author":"P Harter","year":"2019","unstructured":"Harter P, Sehouli J, Lorusso D, et al. A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms. N Engl J Med. 2019;380(9):822\u201332.","journal-title":"N Engl J Med"},{"key":"2074_CR18","doi-asserted-by":"publisher","first-page":"1005898","DOI":"10.3389\/fsurg.2022.1005898","volume":"9","author":"Y Tang","year":"2022","unstructured":"Tang Y, Wen MB, Su B, et al. Early return to work: Single-port vs. multiport laparoscopic surgery for benign ovarian tumor. Front Surg. 2022;9:1005898.","journal-title":"Front Surg"},{"issue":"2","key":"2074_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/POC.0b013e31825a9d3a","volume":"11","author":"CM Curtis","year":"2012","unstructured":"Curtis CM, Kost GJ, Louie RF, et al. POINT-OF-CARE HEMATOLOGY AND COAGULATION TESTING IN PRIMARY, RURAL EMERGENCY, AND DISASTER CARE SCENARIOS. Point care. 2012;11(2):140\u20135.","journal-title":"Point care"},{"issue":"2","key":"2074_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12032-022-01848-z","volume":"40","author":"R Ran","year":"2023","unstructured":"Ran R, Zhong X, Yang Y, et al. Metabolomic profiling identifies hair as a robust biological sample for identifying women with cervical cancer. Med Oncol (Northwood Lond Engl). 2023;40(2):75.","journal-title":"Med Oncol (Northwood Lond Engl)"},{"issue":"4","key":"2074_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ncb3124","volume":"17","author":"LK Boroughs","year":"2015","unstructured":"Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol. 2015;17(4):351\u20139.","journal-title":"Nat Cell Biol"},{"issue":"3215","key":"2074_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1126\/science.124.3215.270","volume":"124","author":"D Burk","year":"1956","unstructured":"Burk D, Schade AL. On respiratory impairment in cancer cells. Sci (New York NY). 1956;124(3215):270\u20132.","journal-title":"Sci (New York NY)"},{"issue":"5","key":"2074_CR23","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.molcel.2016.02.011","volume":"61","author":"WX Zong","year":"2016","unstructured":"Zong WX, Rabinowitz JD, White E. Mitochondria and Cancer. Mol Cell. 2016;61(5):667\u201376.","journal-title":"Mol Cell"},{"issue":"5","key":"2074_CR24","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"5","key":"2074_CR25","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2(5):e1600200.","journal-title":"Sci Adv"},{"key":"2074_CR26","doi-asserted-by":"crossref","unstructured":"Tate S, Nishikimi K, Matsuoka A, Otsuka S, Shozu M. Safety and efficacy of weekly paclitaxel and cisplatin chemotherapy for ovarian cancer patients with hypersensitivity to carboplatin. Cancers (Basel). 2021;13(4):640.","DOI":"10.3390\/cancers13040640"},{"issue":"2","key":"2074_CR27","first-page":"Cd012007","volume":"2","author":"NY Ngoi","year":"2022","unstructured":"Ngoi NY, Syn NL, Goh RM, et al. Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer. Cochrane Database Syst Rev. 2022;2(2):Cd012007.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2074_CR28","doi-asserted-by":"publisher","first-page":"19232","DOI":"10.1038\/s41598-023-46055-6","volume":"13","author":"C Mejia Pe\u00f1a","year":"2023","unstructured":"Mejia Pe\u00f1a C, Skipper TA, Hsu J, et al. Metronomic and single high-dose paclitaxel treatments produce distinct heterogenous chemoresistant cancer cell populations. Sci Rep. 2023;13(1):19232.","journal-title":"Sci Rep"},{"key":"2074_CR29","doi-asserted-by":"crossref","unstructured":"Fasoulakis Z, Koutras A, Ntounis T et al. Ovarian cancer and glutamine metabolism. Int J Mol Sci. 2023;24(5):5041.","DOI":"10.3390\/ijms24055041"},{"issue":"5","key":"2074_CR30","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s13277-012-0381-8","volume":"33","author":"T Granato","year":"2012","unstructured":"Granato T, Midulla C, Longo F, et al. Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer. Tumour biology: J Int Soc Oncodevelopmental Biology Med. 2012;33(5):1335\u20139.","journal-title":"Tumour biology: J Int Soc Oncodevelopmental Biology Med"},{"issue":"4","key":"2074_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1724600820955195","volume":"35","author":"E Potenza","year":"2020","unstructured":"Potenza E, Parpinel G, Laudani ME, et al. Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer. Int J Biol Mark. 2020;35(4):20\u20137.","journal-title":"Int J Biol Mark"},{"issue":"1","key":"2074_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.21873\/anticanres.15492","volume":"42","author":"J Lee","year":"2022","unstructured":"Lee J, Kim JM, Lee YH, Chong GO, Hong DG. Correlation Between Clinical Outcomes and Serum CA-125 Levels After Standard Treatment for Epithelial Ovarian Cancer. Anticancer Res. 2022;42(1):349\u201353.","journal-title":"Anticancer Res"},{"issue":"2","key":"2074_CR33","first-page":"1099","volume":"35","author":"A Gadducci","year":"2015","unstructured":"Gadducci A, Menichetti A, Guiggi I, Notarnicola M, Cosio S. Correlation between CA125 levels after sixth cycle of chemotherapy and clinical outcome in advanced ovarian carcinoma. Anticancer Res. 2015;35(2):1099\u2013104.","journal-title":"Anticancer Res"},{"key":"2074_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ygyno.2023.12.021","volume":"181","author":"A AlSomairi","year":"2024","unstructured":"AlSomairi A, Himayda S, Altelmesani A, Lee YJ, Lee JY. Prognostic value of HE4 in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in comparison to CA125. Gynecol Oncol. 2024;181:155\u201361.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"2074_CR35","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s42255-024-01092-x","volume":"6","author":"AF McGettrick","year":"2024","unstructured":"McGettrick AF, Bourner LA, Dorsey FC, O\u2019Neill LAJ. Metabolic Messengers: itaconate. Nat metabolism. 2024;6(9):1661\u20137.","journal-title":"Nat metabolism"},{"key":"2074_CR36","doi-asserted-by":"publisher","first-page":"102553","DOI":"10.1016\/j.redox.2022.102553","volume":"58","author":"X Shi","year":"2022","unstructured":"Shi X, Zhou H, Wei J, et al. The signaling pathways and therapeutic potential of itaconate to alleviate inflammation and oxidative stress in inflammatory diseases. Redox Biol. 2022;58:102553.","journal-title":"Redox Biol"},{"issue":"1","key":"2074_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12929-025-01186-y","volume":"32","author":"S Sarkar","year":"2025","unstructured":"Sarkar S, Chang CI, Jean J, Wu MJ. TCA cycle-derived oncometabolites in cancer and the immune microenvironment. J Biomed Sci. 2025;32(1):87.","journal-title":"J Biomed Sci"},{"issue":"22","key":"2074_CR38","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.1038\/s44318-024-00217-y","volume":"43","author":"Z Wang","year":"2024","unstructured":"Wang Z, Cui L, Lin Y, et al. Cancer cell-intrinsic biosynthesis of itaconate promotes tumor immunogenicity. Embo j. 2024;43(22):5530\u201347.","journal-title":"Embo j"},{"issue":"2","key":"2074_CR39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1084\/jem.20092506","volume":"207","author":"S Gross","year":"2010","unstructured":"Gross S, Cairns RA, Minden MD, et al. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J Exp Med. 2010;207(2):339\u201344.","journal-title":"J Exp Med"},{"issue":"11","key":"2074_CR40","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1182\/blood-2015-01-621870","volume":"126","author":"N Jacque","year":"2015","unstructured":"Jacque N, Ronchetti AM, Larrue C, et al. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition. Blood. 2015;126(11):1346\u201356.","journal-title":"Blood"},{"issue":"2","key":"2074_CR41","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s13238-017-0451-1","volume":"9","author":"NM Anderson","year":"2018","unstructured":"Anderson NM, Mucka P, Kern JG, Feng H. The emerging role and targetability of the TCA cycle in cancer metabolism. Protein Cell. 2018;9(2):216\u201337.","journal-title":"Protein Cell"},{"key":"2074_CR42","doi-asserted-by":"crossref","unstructured":"Wang Y, Zong X, Mitra S et al. IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells. JCI insight. 2018;3(23):e122360.","DOI":"10.1172\/jci.insight.122360"},{"issue":"11","key":"2074_CR43","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1200\/JCO.1993.11.11.2127","volume":"11","author":"MT Huizing","year":"1993","unstructured":"Huizing MT, Keung AC, Rosing H, et al. Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients. J Clin oncology: official J Am Soc Clin Oncol. 1993;11(11):2127\u201335.","journal-title":"J Clin oncology: official J Am Soc Clin Oncol"},{"key":"2074_CR44","doi-asserted-by":"crossref","unstructured":"Liu N, Yan M, Tao Q et al. Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis. J Immunother Cancer. 2023;11(9):e007146.","DOI":"10.1136\/jitc-2023-007146"},{"issue":"1","key":"2074_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ygyno.2008.09.034","volume":"112","author":"F Muggia","year":"2009","unstructured":"Muggia F. Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer. Gynecol Oncol. 2009;112(1):275\u201381.","journal-title":"Gynecol Oncol"},{"key":"2074_CR46","doi-asserted-by":"publisher","first-page":"1018642","DOI":"10.3389\/fonc.2022.1018642","volume":"12","author":"X Yang","year":"2022","unstructured":"Yang X, Li Z, Ren H, Peng X, Fu J. New progress of glutamine metabolism in the occurrence, development, and treatment of ovarian cancer from mechanism to clinic. Front Oncol. 2022;12:1018642.","journal-title":"Front Oncol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-026-02074-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02074-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-026-02074-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:21:50Z","timestamp":1778034110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-026-02074-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2074"],"URL":"https:\/\/doi.org\/10.1186\/s13048-026-02074-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7296175\/v1","asserted-by":"object"}]},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The written informed consent was acquired from each participant to gather their data anonymously for research purpose. The approval of this study was obtained from Ethics Committee of the Affiliated Nanchong Central Hospital of North Sichuan Medical College (NO.2023-010), and written informed consent was acquired from all participants. All procedures performed in studies involving human participants were in accordance with the 1963 Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This work is original and has not been published elsewhere. All co-authors have reviewed and approved the final version of the manuscript. We agree to the journal\u2019s copyright\/license terms (e.g., CC BY, transfer of copyright).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"177"}}